The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 4th 2025
In the SURPASS-CVOT clinical trial, tirzepatide was non-inferior to dulaglutide in a composite score of cardiovascular outcomes in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD).
AstraZeneca and Heptares Therapeutics enter agreement to develop novel immuno-oncology treatments
August 6th 2015AstraZeneca and Heptares Therapeutics announced that they have entered a licensing agreement which AstraZeneca will acquire exclusive rights to develop the adenosine A2A receptor antagonist, HTL-1071.
Read More
Allergan and KYTHERA Announce that Pending Transaction will now be for All-Cash Consideration
August 5th 2015Allergan plc and KYTHERA Biopharmaceuticals, Inc. today announced that they have amended and restated their merger agreement with respect to Allergan's pending acquisition of KYTHERA.
Read More